Kalvista Pharmaceuticals Inc (KALV)
Operating Cash Flow (Statement)
$45.36M
Quarterly · Period ending: · USD
KALV Operating Cash Flow (Statement)
Latest reported$45.36Mperiod ending
Latest reported$45.36Mperiod ending
KALV Quarterly Cash from Operations (-$1.03M → $45.36M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
KALV operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 45,364,000 | |
| -14,455,000 | |
| -32,680,999 | |
| -54,502,000 | |
| -40,364,000 | |
| -32,681,000 | |
| -39,642,000 | |
| -40,220,000 | |
| -15,105,000 | |
| -27,571,000 | |
| -19,825,000 | |
| -26,730,000 | |
| -22,636,000 | |
| -9,289,000 | |
| -20,594,000 | |
| -22,742,000 | |
| -26,789,000 | |
| -14,065,000 | |
| -19,545,000 | |
| -17,735,000 | |
| -11,045,000 | |
| -7,586,000 | |
| -7,952,000 | |
| -3,588,000 | |
| -12,618,000 | |
| -13,109,000 | |
| -7,814,000 | |
| -11,275,000 | |
| -10,511,000 | |
| -10,856,000 | |
| -8,786,000 | |
| -6,212,000 | |
| -5,955,000 | |
| 28,220,000 | |
| -7,259,000 | |
| -4,448,000 | |
| -2,641,000 | |
| -11,241 | |
| -1,616,000 | |
| -7,260,000 | |
| -5,084,000 | |
| -5,067,000 | |
| -5,306,000 | |
| -6,441,000 | |
| -4,049,000 | |
| -4,337,000 | |
| -3,224,000 | |
| -1,938,000 | |
| -1,754,000 | |
| -1,032,000 |